← Leaderboards
Bharat B Aggarwal
University Of Texas Md Anderson Can Ctr
$1,480,636
Attributed
$1,480,636
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $330.9K · FY2008–12$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,480,636 · 2
By mechanism
P01$1,480,636 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Waun Ki Hong$5,252,991
- Robert C Bast$38,086,401
- Reuben Lotan$1,675,909
- James P Kehrer$2,295,435
- Lei Li$10,104,733
Others in their field
Top investigators on “Collaborations”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$557,285,233
- David Heimbrook · Leidos Biomedical Research, Inc.$519,426,565
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$479,076,140
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Albert Lazzarini · California Institute Of Technology$382,990,355
Research focus
CollaborationsCurcuminCellsCognitiveAnorexiaControlled Clinical TrialsBaseAnimal ModelChemotherapeutic AgentChemotherapyBlood - Brain Barrier AnatomyB Lymphoid MalignancyAggressive CourseConfusionBone MarrowBortezomibBehaviorBrainCancer PatientAnimalsCancer TherapyAfferent NerveCell LineCytokine
Grant awards (7)
TARGETING NF-KB ACTIVATION IN REGULATION OF SYMPTOMS IN PATIENTS WITH MULTIPLE$318,453
P01 · FY2012 · CA · contact PI
TARGETING NF-KB ACTIVATION IN REGULATION OF SYMPTOMS IN PATIENTS WITH MULTIPLE$298,657
P01 · FY2011 · CA · contact PI
TARGETING NF-KB ACTIVATION IN REGULATION OF SYMPTOMS IN PATIENTS WITH MULTIPLE$330,935
P01 · FY2010 · CA · contact PI
TARGETING NF-KB ACTIVATION IN REGULATION OF SYMPTOMS IN PATIENTS WITH MULTIPLE$325,799
P01 · FY2009 · CA · contact PI
TARGETING NF-KB ACTIVATION IN REGULATION OF SYMPTOMS IN PATIENTS WITH MULTIPLE$206,792
P01 · FY2008 · CA · contact PI
TRANSCRIPTION FACTOR NFKB IN LUNG CANCER DEVELOPMENT$0
P01 · FY2002 · CA
TRANSCRIPTION FACTOR NFKB IN LUNG CANCER DEVELOPMENT$0
P01 · FY2001 · CA